Cearvol Wave vs Otofonix Encore

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. The Wave's standout performance is in music streaming, where it scores a strong 4.1/5—a full 2.18 points above the OTC category average. This makes it an unusually capable choice for users who prioritize audio entertainment alongside speech amplification. Speech performance is solid in quiet environments at 3.1/5, sitting 0.36 points above the category average. Speech in noise presents a more mixed picture: while the 2.0/5 score exceeds the category average by 0.56 points, it remains modest in absolute terms—typical of OTC devices without advanced noise management. Own-voice comfort scores 2.1/5, falling 0.41 points below average, which may be noticeable during extended wear. Feedback handling is solid at 3.8/5, though 0.74 points below the category average. The Cearvol Wave is best suited for budget-conscious consumers who want capable music streaming and adequate speech clarity in quieter settings. Those frequently in noisy environments or sensitive to own-voice quality may want to consider alternatives with stronger performance in those areas.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.